Prevalence and determinants of diabetes mellitus among Iranian patients with chronic liver disease

BMC Endocrine Disorders

Volumn 4, Issue , 2004, Pages

  Alavian, Seyed M ^a,b   Hajarizadeh, Behzad ^b   Nematizadeh, Fariborz ^a,b   Larijini, Bagher ^c  

^a BAQIYATALLAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b Tehran Heart Center   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; ORAL ANTIDIABETIC AGENT;

ADULT; AGE; ARTICLE; BODY MASS; CHRONIC LIVER DISEASE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIABETES MELLITUS; DIET RESTRICTION; DISEASE SEVERITY; FAMILY HISTORY; FEMALE; GLUCOSE BLOOD LEVEL; HEPATITIS B VIRUS; HEPATITIS C; HIGH RISK PATIENT; HUMAN; HYPERTENSION; IMPAIRED GLUCOSE TOLERANCE; IRAN; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; OBESITY; PREVALENCE; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM; STATISTICAL ANALYSIS; VIRUS CARRIER;

EID: 10444284894     PISSN: 14726823     EISSN: None     Source Type: Journal    
DOI: 10.1186/1472-6823-4-4     Document Type: Article

References (28)

1. Megyesi C, Samols E, Marks V. Glucose tolerance and diabetes in chronic liver disease. Lancet 1967;2:1051-6
2. Petrides AS, DePronzo RA. Glucose metabolism in cirrhosis: a review with some perspectives for the future. Diabetes Metab Rev 1989;5:691-709
3. Muting D, Wohlgemuth D, Dorsett R. Liver cirrhosis and diabetes mellitus. Geriatrics 1969;24:91-99
4. Kingston ME, Aschraf MA, Atiyeh M, Donnoley RJ. Diabetes mellitus in chronic active hepatitis and cirrhosis. Gastroenterology 1984;87:688-94
5. Buzzelli G, Chiarantini E, Cotrozzi G, Relli P, Matassi L, Romanelli RG, Gentilini P. Estimate of prevalence of glucose intolerance in chronic liver disease. Degree of agreement among some diagnostic criteria. Liver 1988;8(6):354-9
6. Vidal J, Ferre JP, Esmatjes E, Salmeron JM, Gonzalez-Clemente JM, Gomis R, Rodes J. Diabetes mellitus in patients with liver cirrhosis. Diabetes Res Clin Pract 1994;25:19-25
7. Muller MJ, Pirlich M, Balks HJ, Selberg O. Glucose intolerance in liver cirrhosis: role of hepatic and non-hepatic influences. Eur J Clin Chem Clin Biochem 1994;32(10):749-58
8. Bianchi G, Marchesini G, Zoli M, Bugianeci E, Fabbri A, Pisi E. Prognostic significance of diabetes in patients with cirrhosis. Hepatology 1994;20(1):119-125
9. Muller MJ. Are patients with cirrhosis glucose resistant? J Hepatol 1995;22:504-7
10. Zein NN, Abdulkarim AS, Wiesner RH, Egan KS, Persing DH. Prevalence of diabetes mellitus in patients with end-stage liver cirrhosis due to hepatitis C, alcohol, or cholestatic disease. J Hepatol 2000;32:209-17
11. Del Vecchio Blanco C, Gentile S, Marmo R, Carbone L, Coltorti M. Alterations of glucose metabolism in chronic liver disease. Diabetes Res Clin Pract 1990;8:29-36
12. Petit JM, Bour JB, Galland-Jos C, Minello A, Verges B, Guiguet M, Brun JM, Hillon P. Risk factors for diabetes mellitus and early insulin resistance in chronic hepatitis C. J Hepatol 2001;35:279-83
13. American Diabetes Association. American Diabetes Association clinical practice recommendation 2003. Diabetes Care 2003;26(Suppl 1)
14. Azizi F, Rahmani M, Emami H, Mirmiran P, Hajipour R, Madjid M, Ghanbili J, Ghanbarian A, Mehrabi Y, Saadat N, Salehi P, Heydarian P, Sarbazi N, Allahverdian S, Saadati N, Ainy E, Moeini S. Cardiovascular risk factors in an Iranian urban population: Tehran lipid and glucose study (phase I). Soz Praventivmed 2002;47(6):408-26
15. Azizi F, Navai L. [Study of the prevalence of diabetes and impaired glucose tolerance in rural areas of Tehran province] [Article in Persian]. Hakim 2001;4(2):112-8
16. Amini M, Afshin-Nia F, Bashardoost N, Aminorroaya A, Shahparian M, Kazemi M. Prevalence and risk factors of diabetes mellitus in the Isfahan city population (aged 40 or over) in 1993. Diabetes Res Clin Pract 1997;38(3):185-90
17. Mangia A, Schiavone G, Lezzi G, Marmo R, Bruno F, Villani MR, Cascavilla I, Fantasia L, Andriulli A. HCV and diabetes mellitus: evidence for a negative association. Am J Gastroenterol 1998;93(12):2363-7
18. Petrides AS, Schulze-Berg D, Vogt C, Matthews DE, Strohmeyer G. Glucose resistance contributes to diabetes mellitus in cirrhosis. Hepatology 1993;18:284-91
19. Kato M, Asano H, Miwa Y, Tajika M, Yamato M, Tomita E, Tokuyama K, Muto Y, Moriwaki H. Both insulin sensitivity and glucose sensitivity are impaired in patients with non-diabetic liver cirrhosis. Hepatology Research 2000;17:93-101
20. Konrad T, Zeuzen S, Toffolo G, Vicini P, Teuber G, Brien D, Lormann J, Lenz T, Herrmann G, Berger A, Cobelli C, Usadel K. Severity of HCV-induced liver damage alters glucose homeostasis in non-cirrhotic patients with chronic HCV infection. Digestion 2000;62:52-59
21. Tilg H, Diehl AM. Cytokines in alcoholic and non-alcoholic steatohepatitis. N Engl J Med;343(20):1467-76
22. Sanyal AJ, American Gastroenterological Association. AGA technical review on nonalcoholic fatty liver disease. Gastroenterology 2002;123(5):1705-25
23. Mason AL, Lau JYN, Hoang N, Qian K, Alexander GIM, Xu L, Guo L, Jacob Sh, Regenstein FG, Zimmerman R, Everhart JE, Wasserfall C, Maclaren NK, Perrillo RP. Association of diabetes mellitus and chronic hepatitis C infection. Hepatology 1999;29(2):328-33
24. Del Olmo JA, Serra MA, Rodrigo MJ. Liver cirrhosis and diabetes mellitus [letter]. J Hepatol 1996;24:645
25. Hourigan LF, Macdonald GH, Purdie D, Whitehall VH, Shorthouse C, Clouston A, Powell EE. Fibrosis in chronic hepatitis C correlates significantly with body mass index and steatosis. Hepatology 1999;29:1215-9
26. Marchesini G, Ronchi M, Forlani G, Bugianesi E, Bianchi G, Fabbri A, Zoli M, Melchionda N. Cardiovascular disease in cirrhosis. Am J Gastroenterol 1999;94(3):655-62
27. Fattovich G, Giustina G, Favarato S, Ruol A, and Investigators of the Italian Association for the Study of the Liver. A survey of adverse events in 11241 patients with chronic viral hepatitis treated with alfa interferon. J Hepatol 1996;24:34-87
28. Ito Y, Takeda N, Ishimori M, Akai A, Miura K, Yasuda K. Effect of long-term interferon alfa treatment on glucose tolerance in patients with chronic hepatitis. J Hepatol 1999;31:215-220